درباره این اپیزود

انگلیسی
ایالات متحده آمریکا

رونوشت 🔗

جستجوی اپیزودهای گذشته

اپیزودهای قبلی pharmaphorum Podcast را جستجو کن.

قسمت های دیگر در این پادکست

*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech compa…
Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital infrastructure required to deliver prevention at scale isn’t in place. In a new episode of the podcast, pharmaphorum spoke with James Davis, a healthcare expert at PA Consultin…
Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical trials in a significant shift in how regulators think about predictive medicine.  In a new pharmaphorum podcast, Dr Irina Babina, CEO of oncology R&D platform Concr, discusse…
For a variety of reasons, early stage clinical trials have been moving out of the United States more and more over the past few years, as companies pursue savings and lighter regulatory burden in places like China and Australia. The industry has long urged the US government to take some action to m…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به pharmaphorum است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.